Thursday, 23 November 2017

Aurora Cannabis Acquires Leading Global Greenhouse Design Firm Larssen Ltd.

Creating a Turnkey Cannabis Cultivation Powerhouse - ALPS (Aurora Larssen Projects Inc.)

TSX: ACB

VANCOUVER, Nov. 23, 2017 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today that the Company has signed a definitive agreement for the acquisition of 100% of the issued and outstanding shares (the "Acquisition") of Larssen Ltd ("Larssen"). The terms of the transaction are undisclosed, but include performance-based milestone payments, such as those related to profitability metrics, as well as certain Aurora standards.

Larssen, a Canadian company that has set the industry standard in high-tech, automated, environmentally controlled greenhouses for over 30 years, has consulted on the design, engineering, and construction oversight of many of the world's most advanced greenhouse cultivation facilities. Best known for the successful implementation of cutting-edge automation features, proprietary design characteristics that generate exceptional yields, and the use of advanced energy efficient materials and technologies, Larssen has been involved with over 1,000 projects around the globe.

Following a thorough review process, Aurora selected Larssen to design, engineer, and oversee construction of its Aurora Sky facility, which upon completion is expected to be the largest capacity and most technologically advanced cannabis facility in the world, producing ultra-low cost, premium-quality cannabis. Larssen is currently involved with over 15 cannabis industry clients globally, including 5 Canadian licensed producers. The Canadian deals will be vetted by the Company's management team. Any Canadian project deemed not to be in the best interest of Aurora shareholders will be notified that ALPS will no longer participate in such project. We expect this process to take no longer than 3 weeks.

Upon completion of the transaction, Larssen will be integrated into a newly incorporated subsidiary, Aurora Larssen Projects Ltd. ("ALPS"), focused on providing a unique turn-key service offering to Aurora and its domestic and international partners, that will over time provide 360-degree solutions for facility design, engineering, construction, support, maintenance, security, regulatory support, cultivation, genetics, as well as provide consulting and assistance in regard to meeting requirements for GACP cultivation and EU GMP certification.

Thomas Larssen, the principal of Larssen, will serve as President of ALPS and will continue to oversee Aurora's cultivation infrastructure expansion. Management anticipates that the growth of ALPS will be driven by the continued rapid evolution of the cannabis industry in Canada and around the globe.

"The acquisition of Larssen is an immediately accretive, high-margin revenue generating opportunity that also extends our technological leadership in the cannabis sector," said Terry Booth, CEO. "We know Thomas and his team very well, as they have been instrumental in the design and engineering of our revolutionary Aurora Sky facility. This will help make the integration of Larssen with Aurora seamless. The establishment of ALPS will add significant capacity to our project execution team, enabling us to further accelerate the expansion of our global presence. I look forward to working with Thomas and his team as we pursue new opportunities going forward."

Differentiating transaction with strong strategic rationale

  • For fiscal 2018 (the 12-month period ending September 30, 2018), Larssen is on pace to generate approximately $6 million in revenues, with an EBITDA margin exceeding 40%.
  • Through direct ownership and providing a stronger supportive infrastructure, Larssen will be able to dedicate additional resources to developing unique technologies exclusively for Aurora, further extending the Company's industry-leading innovation track record;
  • Given Larssen's reputation and visibility within the industry, Aurora will gain immediate access to an expanded universe of international M&A and partnership opportunities;
  • Aurora is executing on an aggressive expansion strategy that is likely to include further construction projects. Through Larssen, the Company will have secured direct access to the services of the world's pre-eminent turn-key project team in the cannabis sector, enabling management to focus on growing Aurora rather than allocating significant resources to project management, as well as save considerable project-related expenses going forward.

Thomas Larssen, Principal of Larssen, added, "We have been at the cutting edge of greenhouse development for over 30 years, and have never encountered a team that matches the vision, entrepreneurship and execution as demonstrated by the people at Aurora. Our decision to join forces with Aurora in this evolving industry was not difficult. Joining the Company will allow us to leverage the incredible brand recognition Aurora enjoys, both within and outside of the cannabis sector. I believe that the resources, infrastructure and strategic support available at Aurora will help establish ALPS as the world's leading horticultural engineering venture, and I look forward to making my contribution to the continued rapid expansion of the Company."

Neil Belot, Chief Global Business Development Officer said, "The acquisition of Larssen, and the creation of ALPS is another truly differentiating transaction that exemplifies the Aurora Standard, and separates us from our competition. Through the integration of our top-calibre teams, we will rapidly introduce additional high-quality, high-yield, ultra-efficient cannabis specialized greenhouse and post-harvest processing facilities to new countries and partners around the globe."

The Acquisition is subject to the completion of customary closing conditions and the Company anticipates completing the Acquisition within the coming weeks.

About Aurora

Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations ("ACMPR"). The Company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, known as "Aurora Mountain", a second 40,000 square foot high-technology production facility known as "Aurora Vie" in Pointe-Claire, Quebec on Montreal's West Island, and is currently constructing an 800,000 square foot production facility, known as "Aurora Sky", at the Edmonton International Airport.

In addition, the Company holds approximately 9.6% of the issued shares (12.9% on a fully-diluted basis) in leading extraction technology company Radient Technologies Inc., based in Edmonton, and is in the process of completing an investment in Edmonton-based Hempco Food and Fiber for an ownership stake of up to 50.1%. Furthermore, Aurora is the cornerstone investor with a 19.9% stake in Cann Group Limited, the first Australian company licensed to conduct research on and cultivate medical cannabis. Aurora also owns Pedanios, a leading wholesale importer, exporter, and distributor of medical cannabis in the European Union, based in Germany. The Company offers further differentiation through its acquisition of BC Northern Lights Ltd. and Urban Cultivator Inc., industry leaders, respectively, in the production and sale of proprietary systems for the safe, efficient and high-yield indoor cultivation of cannabis, and in state-of-the-art indoor gardening appliances for the cultivation of organic microgreens, vegetables and herbs in home and professional kitchens. Aurora's common shares trade on the TSX under the symbol "ACB".

On behalf of the Board of Directors,
AURORA CANNABIS INC.

Terry Booth
CEO                                                                                                                               

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"), including, but not limited to, statements with respect to the closing of the Acquisition and the performance of the Company, including, but not limited to, Aurora Larssen Projects Inc. Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Aurora Cannabis Inc.

CONTACT: Cam Battley, Executive Vice President, +1.905.864.5525, cam@auroramj.com, www.auroramj.com; Marc Lakmaaker, Director, Investor Relations and Corporate Development, +1.647.289.6640, marc.lakmaaker@auroramj.com

Wednesday, 22 November 2017

iXledger and fidentiaX Announce Strategic Partnership to Disrupt the Insurance Industry


SINGAPORE, SINGAPORE, November 22, 2017 /EINPresswire.com/ -- Xledger is a ground-breaking alternative marketplace for insurers, reinsurers and brokers to trade insurance products directly and has announced that it has entered into a strategic partnership with fidentiaX, the world's 1st marketplace for tradable policies powered by blockchain technology.



Both companies are building blockchain solutions to democratize the insurance industry and to streamline the opacity and byzantine operating standards of the sector. fidentiaX's marketplace empowers Policyholders to monetize their existing insurance policies for higher value and Buyers to invest in an asset class not easily available previously.

This new Strategic Partnership will create synergy between iXledger and fidentiaX platforms to deliver a secured, transparent and efficient end-to-end experience for Businesses (Insurers, Reinsurers, and Brokers) and Consumers (Policyholders).

As part of the partnership, iXledger will be allocating resources towards fidentiaX's development of its Tradable Insurance Marketplace as well as technology collaboration between the two disruptive marketplaces. fidentiaX's core team's experience in the consumer segment strategy and wealth management knowledge will provide iXledger with insights which will enhance the customer experience and delivery of its platform.

"We are excited at the prospect of working with iXledger, their input and experience in the "up-stream" of the insurance lifecycle, will enable us to enhance fidentiaX's marketplace services and accelerate our objective of empowering policyholders to extract higher value from their policies." Alvin Ang, Co-founder of fidentiaX

"It is a great opportunity for us to collaborate with fidentiaX with their expertise in the consumer market and their ground-breaking technology. We have already identified a number of synergies and having a partner in a different region with similar goals is a huge advantage." Ingemar Svensson, Founder/CEO of iXledger

About iXledger

iXledger is a groundbreaking alternative marketplace for insurance. The blockchain based platform facilitates improved customer service, fuels new efficient business models, drives faster transactions and reduces risk through data access and collaboration.

About fidentiaX

fidentiaX is a Singapore-based fintech startup that was launched in 2017 to disrupt the insurance market by leveraging blockchain technology to create an active market for tradable life insurance policies. The fidentiaX founding team consists of industry veterans with more than 35 years of experience in the banking and insurance industry. To develop the platform, fidentiaX has partnered up with blockchain development company Blockchain Zoo.

Media Contact

If you want to find out more about fidentiaX please visit www.fidentiaX.com or contact the company at:

Contact Email: info@fidentiax.com
Location: Singapore
Phone: ++65 6908 0071
Facebook: www.facebook.com/fidentiaX
Twitter: www.twitter.com/fidentiaX
Telegram: www.t.me/fidentiaX

Alvin Ang
Mr
90625646


Global Industrial Enzymes Market is Projected to Reach US$8.536 billion by 2022

RAIPUR, INDIA, November 22, 2017 /EINPresswire.com/ --

Report Sellers has added a new market research report "Industrial Enzymes Market- Forecasts from 2017 to 2022" to its offerings. The report is an in-depth market study providing accurate market insights including the latest trends, forecast, competitive insights, etc.

According to the report, Industrial Enzymes market is projected to witness a CAGR of 6.92% to reach US$8.536 billion by 2022, increasing from US$6.107 billion in 2017.

Booming processed food and beverage industry is augmenting the demand for industrial enzymes to enhance the products texture, taste, and flavor. Rising demand for cosmetics and personal care products due to growing global aging population and awareness are contributing to the global industrial enzymes market growth.

Growing consciousness concerning good health and fitness is leading to the high demand for nutraceuticals which will bolster the growth of digestive and nutritional enzymes, thereby positively impacting the industrial enzymes market growth over the next five years. Furthermore, the demand for enzymes will intensify during the forecast period owing to increasing application in animal feed products to boost digestibility and nutritional value of the feed.

Competitive Insights: Prominent key market players in Industrial Enzymes market include Novozymes, DuPont, BASF, and DSM among others. The global industrial enzymes industry is competitive owing to the presence of a considerable number of global market players. To maintain their position and gain bigger market share, key players are engaged in growth strategies including high investment in R&D, new product launches, and strategic collaborations and partnerships. In October 2016, BASF launched Lavergy, a new enzyme product line, for detergents and cleaning industry.

Browse through the complete description and in-depth TOC on "Industrial Enzymes Market"
https://www.reportsellers.com/market-research-report/Industrial-Enzymes-Market---Forecasts-from-2017-to-2022

Report Scope

Industrial Enzymes market is segmented by product, source, end use industry, and geography:

By Product

  • Lipases
  • Nucleases
  • Carbohydrase
  • Polymerases
  • Others

By Source

  • Animal
  • Plant
  • Microorganism

By End Use Industries

  • Food and Beverage
  • Paper and Pulp
  • Cosmetics
  • Pharmaceuticals
  • Wastewater
  • Animal Feed
  • Others

By Geography

  • Americas
    • North America
    • U.S.
    • Canada
    • Mexico
    • Others
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe Middle East and Africa
    • Europe
    • UK
    • Germany
    • France
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Others

We have a large number of reports in Manufacturing & Construction industry which can be accessed in the following link: https://www.reportsellers.com/category/manufacturing-construction-market-research-report

About Report Sellers

Report Sellers is a premium market research service provider offering market reports in varied sectors. We have a team of experienced analysts and publishers who continuously track the latest trends in different industries.Report Sellers is a brand of global repute and offers the best suited research services to its clients globally in the most satisfying manner. We have a strong network of industry experts who have successfully delivered complex research assignments in niche and top markets.

Drop an enquiry for any research requirement: https://www.reportsellers.com/contact-us or send us an email: sales@reportsellers.com

Aditya Joshi
Report Sellers
+1-214-396-2385

Global Alpha Synuclein Market Competition by Top Manufacturers - ReportsnReports

PUNE, India, November 22, 2017 /PRNewswire/ --

Alpha Synuclein Market presents 2017-22 notable investigation of the Alpha Synuclein Industry alongside the key elements which are Industry Analysis, Insights, Application, Services and development of the market, accessible at ReportsnReports.

The report gives a comprehensive estimation of the Alpha Synuclein Market involving industry chain structure, advertise drivers, openings, future guide, industry news investigation, industry arrangement examination, showcase player profiles and procedures. The report offers a far reaching knowledge into the advancement approaches and designs notwithstanding producing procedures and cost structures.

Complete report on Alpha Synuclein market spread across 117 pages, profiling 14 companies and supported with 197 tables and figures is now available athttp://www.reportsnreports.com/reports/1238418-global-alpha-synuclein-market-research-report-2017.html.

With tables and figures examining overall Alpha Synuclein Market, this examination gives key measurements on the condition of the business and is a significant wellspring of direction and course for organizations and people intrigued by the market. Organizations profiled and contemplated for this Alpha Synuclein Market report incorporate AC Immune SA, AFFiRiS AG, BioArctic AB, Biogen Inc, Evotec AG, Genmab A/S, H. Lundbeck A/S, ICB International Inc, MedImmune LLC, Neuropore Therapies Inc, nLife Therapeutics SL, Prothena Corp Plc, QR Pharma Inc, reMYND NV and others. Order a copy of Global Alpha Synuclein Market Report 2017 athttp://www.reportsnreports.com/purchase.aspx?name=1238418.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into 

AV-1950R, AV-1947D, BAN-0805, BIIB-054, DPC-003 and Others.

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including 

Multiple System Atrophy, Neurodegenerateive Disease, Lewy Body Dementia and Others.

The significant Alpha Synuclein Market (counting North America, Europe, China, Japan, Southeast Asia, India, and so forth.) is broke down, information including: Market size, import and fare, deal section advertise by item sort and applications. At that point we estimate the 2017-2022 market size of Alpha Synuclein. The report concentrates on worldwide real driving organizations giving data, for example, organization profiles, deals, deals income, piece of the pie and contact data. At long last the showcasing, plausibility of new venture ventures are surveyed and general research conclusions advertised.

Related research titled: 

"2017 Market Research Report on United States Alpha Olefins Market" focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The United States Alpha Olefins Industry development trends and marketing channels are analyzed.

Alpha Olefins Market consists With 192 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. 2017 Major Manufacturers Analysis of Alpha Olefins are Royal Dutch Shell PLC, ExxonMobil Corporation, Chevron Phillips Chemical Company LLC, Dow Chemical, Saudi Basic Industries Corporation (SABIC), Idemitsu Kosan, Qatar Chemical Company Ltd (Q-chem), Sasol Limited, INEOS Oligomers. Browse a copy of complete research report at http://www.reportsnreports.com/reports/1232233-united-states-alpha-olefins-market-report-2017.html.

About Us: 

ReportsnReports.com is computerized databank of syndicated Market reports for worldwide and China organizations. We offers statistical surveying reports to organizations, elements and associations with a target of helping them in their basic leadership process. Our gathering of 500,000+ industry and country explore reports shields 5000+ small scale markets. We give 24X7 accessible, on the web and disconnected help to our customers.

Connect with us: 

Facebook: https://www.facebook.com/pages/ReportsnReports/191441427571689

LinkedIn: http://www.linkedin.com/company/reportsnreports

Twitter: https: //twitter.com/marketsreports

G+ / Google Plus: https://plus.google.com/111656568937629536321/posts

Pinterest: http://www.pinterest.com/comeonseo/reportsnreports/

RSS/Feeds: http://www.reportsnreports.com/feed/l-latestreports.xml

Contact: 
Hrishikesh Patwardhan
Corporate Headquarters
2nd floor, metropole,
Next to inox theatre,
Bund garden road, Pune-411001.
+1-888-391-5441
sales@reportsandreports.com

SOURCE ReportsnReports

Examining The EKO token: EchoLink Creates New Currency For Professional Recruitment

PALO ALTO, Calif., Nov. 22, 2017 /PRNewswire-USNewswire/ -- EchoLink, a blockchain-based recruiting and professional networking platform, is announcing the launch of a new digital cryptocurrency. Known as the EchoLinkToken (the EKO token), or EKO, this currency helps the platform obtain key information from databases across the globe.

EchoLink is designed to eliminate the problems inherent in traditional recruiting. By creating an immutable list of records on workers taken from a wide variety of different sources, it helps employers and hiring managers quickly obtain accurate information on all aspects of an applicant. This speeds up the hiring process and minimizes the chance that an employee will be selected without undergoing full vetting.

The EchoLinkToken (EKO)  enhances these recruiting services by making it easier for the EchoLink platform to gain access to other databases. It also provides a universal standard for value, allowing the platform to be more easily adopted across borders and economies. Along with giving users an incentive to make the system as accurate and reliable as possible, this coin will vastly improve the popularity and effectiveness of EchoLink for recruiting.

EchoLink's Solution to Recruitment Pitfalls

The modern recruiting process is subject to a range of different flaws, most of which relate to one central problem: lack of access to accurate information. Employers and hiring managers need to know as much as possible about job applicants, including not just their formal credentials and past employers, but also subtler skills and personality traits. Yet employees are often not willing to divulge this information, and even those who would be willing may not know that employers want it. Businesses can get around this problem by hiring professional recruiters, but that adds to the cost of the process while making it take longer. Recruiters also are not perfectly reliable, being subject to countless biases and perverse incentives.

EchoLink eliminates these problems by providing a secure database on all information that employers might need for recruitment. To keep this information abundant and accurate, it takes advantage of:

  • Blockchain Technology- The cornerstone of the EchoLink system, blockchain technology is a method of tying multiple pieces of information to each other in such a way that when one datum changes, all the other data change with it. This makes it effectively impossible for employees to alter any background or credential information entered about them. In this way, EchoLink cuts down on false or misleading employee claims.
  • Identity Mapping- Besides preventing employees from editing existing information, EchoLink stops the unauthorized addition of new information. By using advanced identity mapping, the platform determines exactly who is adding to it at any given time. This prevents anyone from contributing information under false pretenses.
  • Database Connections- To assemble as much information as possible, EchoLink establishes links to other blockchain databases across the globe. Through self-enforcing or "smart" contracts, it automatically uploads new information on each applicant from these databases as soon as possible. This allows employers and hiring managers to consider the full person who is applying, and it makes it harder for employees to hide the context behind their purported skills and experiences.
  • Dynamic Browsing- With such a large and growing volume of data, EchoLink risks overwhelming its users with information. To keep this risk to a minimum, it has adopted dynamic browsing, which lets employers and hiring managers retrieve the specific information they need on each applicant.

Through these and other steps, EchoLink has the potential to not only improve the accuracy of the vetting process, but also to speed it up. It makes vast bodies of specific information available upon request, allowing employers and hiring managers to quickly get the data they need and begin studying it. As a result, businesses will have more time to think critically about each potential hire, raising recruitment quality on multiple fronts.

How EKO Fits into the EchoLink Puzzle

As beneficial as the EchoLink platform is, it only works if it gets large numbers of other databases around the world on board. But given the wildly different cultural, economic, and organizational backgrounds of each blockchain database, this is easier said than done. Typically, a platform like EchoLink could simply pay for access to other databases. But given that it needs information from as many countries as possible, this may not work for those operating in unstable economies or with devalued currencies.

The EchoLinkToken (EKO)  offers a convenient solution to this issue. Rather than conducting business in dollars, rupees, or other national currencies, EchoLink will issue its own coins. Using the blockchain, it can set the value of these coins at a certain amount of database information. It will then program smart contracts to automatically pay other databases in EKO every time they provide new information to an employer, hiring manager, or other user.

Not only do EKO payments allow other databases to access a consistent source of remuneration, but they tie those databases' success to that of the EchoLink platform as a whole. The more databases use the platform, the more valuable it will be to employers, driving more businesses to sign up for it and buy coins. As businesses buy more coins, they will bid up those coins' value in other currencies, meaning databases can make more money for the same amount of EKO payments. As a result, databases have a strong incentive to join EchoLink and provide quality information.

Besides enhancing incentives, EKO will give the EchoLink platform a common system of value in which to measure quality of education, skills, and other credentials. Businesses who use the platform can thus more easily understand the value they are getting with each employee, no matter where they're located or what kinds of workers they need.

CONTACT: Steve Chen, steve@echolink.tech


 

SOURCE EchoLink

Catch Rishi Raj (AIR 27, CSE 2017) live on Chanakya IAS Academy’s Facebook and YouTube Channel on 19th May 2018

  Live Streaming with Rishi Raj (AIR 27, CSE 2017) from 11:30 am onwards on May 19th, 2018 at Chanakya IAS Academy's Website, Facebo...